San Francisco Sentry Investment Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2K Buy
+16
New +$1.54K ﹤0.01% 636
2020
Q4
Sell
-20
Closed -$2K 702
2020
Q3
$2K Buy
+20
New +$2.09K ﹤0.01% 605
2018
Q4
Sell
-28
Closed -$1K 1003
2018
Q3
$1K Buy
+28
New +$868 ﹤0.01% 850
2017
Q4
Sell
-200
Closed -$2K 912
2017
Q3
$2K Buy
+200
New +$3.54K ﹤0.01% 837

Other funds holding DXCM

San Francisco Sentry Investment Group's DXCM Position: Q2 2021 in Review

San Francisco Sentry Investment Group opened a new position in DexCom (DXCM) in Q2 2021: 16 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings. This is a return to the name: San Francisco Sentry Investment Group previously reported a position in DXCM as recently as Q3 2020.

San Francisco Sentry Investment Group first reported a position in DXCM in Q3 2017 and has held it in 4 quarters since. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • San Francisco Sentry Investment Group held 16 shares of DexCom worth $2K as of Q2 2021.
  • DexCom was a new San Francisco Sentry Investment Group position in Q2 2021.
  • DexCom made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #636 holding.
  • San Francisco Sentry Investment Group first reported a position in DexCom in Q3 2017 and has held it in 4 quarters since.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.